STK11 and neoplasm: Other studies confirmed beforementioned results regarding STK11/LKB1 co-mutations [42,43,44], suggesting that LKB1-deficient tumor cells stimulate neutrophil recruitment through the production of cytokines and chemokines and changes in metabolic reprogramming, which lead to a worse prognosis in such patients [42,43].